Clinical Trial Update: Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluating suicide gene therapy in combination with chemoradiotherapy for non-metastatic pancreatic adenocarcinoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Snippet

Sponsor: Henry Ford Health System | Conditions: Pancreatic Cancer | Phase 1 | Status: TERMINATED